- Home
- CNFR vs PMCB Comparison
CNFR vs PMCB Comparison
Compare CNFR & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNFR
- PMCB
- Stock Information
- Founded
- CNFR 2009
- PMCB 1996
- Country
- CNFR United States
- PMCB United States
- Employees
- CNFR N/A
- PMCB N/A
- Industry
- CNFR Property-Casualty Insurers
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNFR Finance
- PMCB Health Care
- Exchange
- CNFR Nasdaq
- PMCB Nasdaq
- Market Cap
- CNFR 13.7M
- PMCB 11.4M
- IPO Year
- CNFR 2015
- PMCB N/A
- Fundamental
- Price
- CNFR $1.00
- PMCB $1.76
- Analyst Decision
- CNFR
- PMCB
- Analyst Count
- CNFR 0
- PMCB 0
- Target Price
- CNFR N/A
- PMCB N/A
- AVG Volume (30 Days)
- CNFR 4.2K
- PMCB 27.2K
- Earning Date
- CNFR 04-03-2025
- PMCB 03-17-2025
- Dividend Yield
- CNFR N/A
- PMCB N/A
- EPS Growth
- CNFR N/A
- PMCB N/A
- EPS
- CNFR 2.40
- PMCB 0.74
- Revenue
- CNFR $74,815,000.00
- PMCB N/A
- Revenue This Year
- CNFR N/A
- PMCB N/A
- Revenue Next Year
- CNFR $7.00
- PMCB N/A
- P/E Ratio
- CNFR $0.41
- PMCB $2.37
- Revenue Growth
- CNFR N/A
- PMCB N/A
- 52 Week Low
- CNFR $0.65
- PMCB $1.39
- 52 Week High
- CNFR $1.91
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- CNFR 45.41
- PMCB 60.08
- Support Level
- CNFR $0.96
- PMCB $1.57
- Resistance Level
- CNFR $1.07
- PMCB $1.66
- Average True Range (ATR)
- CNFR 0.04
- PMCB 0.12
- MACD
- CNFR 0.01
- PMCB 0.02
- Stochastic Oscillator
- CNFR 47.78
- PMCB 68.89
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance company engaged in the sale of property and casualty insurance products. It is engaged in three classes of insurance businesses namely commercial lines, personal lines, and wholesale agency business. Within these three businesses, the company offers various insurance products and insurance agency services. The company views the commercial and personal lines segments as underwriting business. The wholesale agency business provides non-risk bearing revenue through commissions and policy fees. Its revenues are derived from premiums earned from insurance operations.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.